JP Morgan Chase’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

JP Morgan Chase’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-103,940	Closed	-$6.46M	–	8059
2023 Q4	$6.46M	Buy	+103,940	New	+$2.58M	﹤0.01%	2860

JP Morgan Chase's RYZB Position: Q1 2024 in Review

JP Morgan Chase sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 103,940 shares — an estimated $6.46M sold.

JP Morgan Chase first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $6.46M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

JP Morgan Chase reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
JP Morgan Chase sold 103,940 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $6.46M.
JP Morgan Chase first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
JP Morgan Chase's RayzeBio, Inc. Common Stock position peaked at $6.46M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.